This novel signal 1, in combination with ATP, whose concentration is significantly enhanced within extracellular spaces and interstitial fractions in CRC [67], licenses the maturation and secretion of IL-1β at levels comparable to those seen upon LPS/ATP treatment. The gene discussed is IL1B; the disease is colorectal carcinoma.